Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $30.71 Billion |
|---|---|
| Enterprise Value | $217.41 Billion |
| Annual dividend | $0.50 |
| Dividend yield | 2.93% |
| Earnings per Share | $164.57 |
| Beta | 0.09 |
| Outstanding Shares | 1,796,053,000 |
| P/E Ratio | 12.54 |
|---|---|
| PEG | 0.07 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | 0.09 |
| Enterprise Value to EBIT | 0.37 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 1.95 |
| Debt to Equity | 0.21 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Astellas Pharma Inc., a venerable Japanese pharmaceutical enterprise established in 1923 and headquartered in Tokyo, operates globally in the research, development, manufacturing, and commercialization of a diverse range of medications. ...